Drax Exametazime 0.5 mg Powder For Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02495848) held by Jubilant Draximage Inc. Dba Jubilant Radiopharma, containing Exametazime. Health Canada lists its status as Marketed (status date 27 Feb 2026). Nexara Health has matched 15 registrations of Exametazime across 7 other regulated markets.
Health Canada registration
| DIN | 02495848 |
|---|---|
| Brand name | Drax Exametazime |
| Active ingredient | Exametazime |
| Strength | 0.5 mg |
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Company | Jubilant Draximage Inc. Dba Jubilant Radiopharma |
| Status | Marketed — 27 Feb 2026 |
| Class | Radiopharmaceutical |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Exametazime registered in other markets
15 registrations of the same molecule in 7 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Czech Republic | Brain-Spect Kit | — | 0,3MG | Rad Kit | R | SUKL DLP |
| Czech Republic | Exametazim Radiopharmacy Laboratorium | — | 500MCG | Rad Kit | R | SUKL DLP |
| Czech Republic | Stabilised Ceretec | — | 500MCG | Rad Kit | R | SUKL DLP |
| Denmark | Medi-Exametazim | Radiopharmacy Laboratory Ltd. | 500 mikrogram | radiofarmaceutisk præparationssæt | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Stabilised Ceretec | GE Healthcare AS | radiofarmaceutisk præparationssæt | National | Laegemiddelstyrelsen | |
| Hong Kong | Ceretec For Inj | Ge Medical Systems Hong Kong Limited | Registered | DH Drug Office | ||
| Iceland | Ceretec | Icepharma - óskráð | stl | 0 | Lyfjastofnun lyfjaverdskra | |
| Iceland | Ceretec | Icepharma - óskráð | stl | 0 | Lyfjastofnun lyfjaverdskra | |
| Malta | Ceretec - Kit for the preparation of Technetium [99mTc] Exametazime Injection | GE Healthcare AS | Powder For Solution For Injection | Withdrawn | Medicines Authority | |
| Netherlands | Ceretec 0,5 mg kit voor radiofarmaceutische preparaat | GE Healthcare B.V. | Kit voor radiofarmaceutisch preparaat | Uitsluitend recept | EU national register | |
| Netherlands | Exametazime Radiopharmacy 0,5 mg kit voor radiofarmaceutisch preparaat | Radiopharmacy Laboratory Ltd | Kit voor radiofarmaceutisch preparaat | Uitsluitend recept | EU national register | |
| Netherlands | Stabilised Ceretec, 0,5 mg kit voor radiofarmaceutisch preparaat | GE Healthcare B.V. | Kit voor radiofarmaceutisch preparaat | Uitsluitend recept | EU national register | |
| Taiwan | Ceretec | Ge Healthcare Limited | 凍晶注射劑 | 已註銷 | TFDA | |
| Taiwan | Iner Hmpao Kit | 國家原子能科技研究院核醫製藥中心 | 凍晶注射劑 | Registered | TFDA | |
| Taiwan | Medi-Exametazime 500 micrograms Kit for radiopharmaceutical preparation | Medi-Radiopharma Ltd. | 凍晶注射劑 | Registered | TFDA |
See every manufacturer of Exametazime worldwide →
Regulator price references for Exametazime
Published list or reimbursement prices for Exametazime presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Ceretec | hgl | 49,628.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Ceretec | hgl | 141,794.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Drax Exametazime (DIN 02495848) marketed in Canada?
Yes. Health Canada lists DIN 02495848 as Marketed as of 27 Feb 2026.
Who holds the Canadian licence for this product?
Jubilant Draximage Inc. Dba Jubilant Radiopharma is the company of record in the Health Canada Drug Product Database.
Is Exametazime registered outside Canada?
Yes — Nexara Health has matched 15 registrations in 7 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02495848, status date 2026-02-27; national medicine registries: DH Drug Office, EU national register, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, SUKL DLP, TFDA; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02495848, status date 2026-02-27; national medicine registries: DH Drug Office, EU national register, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, SUKL DLP, TFDA; price sources: Lyfjastofnun lyfjaverdskra.
Health Canada Drug Product Database (DPD), DIN 02495848, status date 2026-02-27; national medicine registries: DH Drug Office, EU national register, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, SUKL DLP, TFDA; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.